| Osteoporosis | QS149 | | |
| Pegylated liposomal irinotecan for treating pancreatic cancer after gemcitabine | TA440 | | |
| Ixekizumab for treating moderate to severe plaque psoriasis | TA442 | | |
| Obeticholic acid for treating primary biliary cholangitis | TA443 | | |
| VAAFT for treating anal fistulae | MIB102 | | |
| Antisocial behaviour and conduct disorders in children and young people: recognition and management | CG158 | | |
| Alcohol-use disorders: diagnosis and management of physical complications | CG100 | | |
| Sexually transmitted infections: condom distribution schemes | NG68 | | |
| Minimally invasive sacroiliac joint fusion surgery for chronic sacroiliac pain | HTG436 | | |
| Irritable bowel syndrome in adults: diagnosis and management | CG61 | | |
| Managing medicines for adults receiving social care in the community | NG67 | | |
| Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal) | TA240 | | |
| Alectinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer (terminated appraisal) | TA438 | | |
| Mitochondrial disorders in children: Co-enzyme Q10 | ES11 | | |
| Mollii suit for spasticity | MIB100 | | |
| Bair Hugger for measuring core temperature during perioperative care | MIB99 | | |
| Patient group directions | MPG2 | | |
| Elotuzumab for previously treated multiple myeloma (terminated appraisal) | TA434 | | |
| Tenofovir alafenamide for treating chronic hepatitis B (terminated appraisal) | TA435 | | |
| Bevacizumab for treating EGFR mutation-positive non-small-cell lung cancer (terminated appraisal) | TA436 | | |
| Ibrutinib with bendamustine and rituximab for treating relapsed or refractory chronic lymphocytic leukaemia after systemic therapy (terminated appraisal) | TA437 | | |
| Extraurethral (non-circumferential) retropubic adjustable compression devices for stress urinary incontinence in women | HTG434 | | |
| Sacrocolpopexy with hysterectomy using mesh to repair uterine prolapse | HTG435 | | |
| Hyperhidrosis: oxybutynin | ES10 | | |
| Mental health of adults in contact with the criminal justice system | NG66 | | |
| Narcolepsy with or without cataplexy in adults: pitolisant | ES8 | | |
| Skin involvement in systemic sclerosis: rituximab | ES7 | | |
| TopClosure Tension Relief System for wound closure | MIB97 | | |
| SimpliCT laser-guided needle placement in interventional radiology | MIB98 | | |
| Head and neck cancer | QS146 | | |
| Healthy workplaces: improving employee mental and physical health and wellbeing | QS147 | | |
| Community engagement: improving health and wellbeing | QS148 | | |
| Ustekinumab for treating active psoriatic arthritis | TA340 | | |
| Ustekinumab for treating moderate to severe plaque psoriasis | TA180 | | |
| Care of dying adults in the last days of life | QS144 | | |
| Intrapartum care | QS105 | | |
| Molecular testing strategies for Lynch syndrome in people with colorectal cancer | HTG430 | | |
| Migalastat for treating Fabry disease | HST4 | | |
| Drug misuse prevention: targeted interventions | NG64 | | |
| Everolimus for advanced renal cell carcinoma after previous treatment | TA432 | | |
| Apremilast for treating active psoriatic arthritis | TA433 | | |
| Lateral interbody fusion in the lumbar spine for low back pain | HTG431 | | |
| Trabecular stent bypass microsurgery for open-angle glaucoma | HTG432 | | |
| Healthcare-associated infections: prevention and control in primary and community care | CG139 | | |
| Severe sialorrhoea (drooling) in children and young people with chronic neurological disorders: oral glycopyrronium bromide | ES5 | | |
| Smart One for measuring lung function | MIB96 | | |
| U-Drain for people needing night drainage of urine or dialysis fluid | MIB95 | | |
| Menopause | QS143 | | |
| HumiGard for preventing inadvertent perioperative hypothermia | HTG428 | | |
| Osteoporosis: assessing the risk of fragility fracture | CG146 | | |
| eazyplex SuperBug kits for detecting carbapenemase-producing organisms | MIB94 | | |
| Stable angina | QS21 | | |
| Cerebral palsy in under 25s: assessment and management | NG62 | | |
| Antimicrobial stewardship: changing risk-related behaviours in the general population | NG63 | | |
| Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation | TA429 | | |
| Sofosbuvir–velpatasvir for treating chronic hepatitis C | TA430 | | |
| Boston Keratoprosthesis Type I for corneal blindness | MIB91 | | |
| CentriMag for heart failure | MIB92 | | |
| Ekso exoskeleton for rehabilitation in people with neurological weakness or paralysis | MIB93 | | |
| Refractory extrapulmonary sarcoidosis: infliximab | ES4 | | |
| Smartinhaler for asthma | MIB90 | | |
| Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib | TA427 | | |
| Learning disability: identifying and managing mental health problems | QS142 | | |
| Tuberculosis | QS141 | | |
| Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation | CG135 | | |
| Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimens | TA423 | | |
| Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancer | TA424 | | |
| Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemia | TA425 | | |
| Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia | TA426 | | |
| Everolimus with exemestane for treating advanced breast cancer after endocrine therapy | TA421 | | |
| Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer | TA422 | | |
| Extracorporeal shockwave therapy for Achilles tendinopathy | HTG426 | | |
| Radiation therapy for early Dupuytren's disease | HTG427 | | |
| Pulmonary sarcoidosis: infliximab | ES2 | | |
| Blood transfusion | QS138 | | |
| Oral health promotion in the community | QS139 | | |
| Hypothermia: prevention and management in adults having surgery | CG65 | | |
| Ticagrelor for preventing atherothrombotic events after myocardial infarction | TA420 | | |
| Epiduroscopic lumbar discectomy through the sacral hiatus for sciatica | HTG425 | | |
| XprESS multi sinus dilation system for treating chronic sinusitis | HTG424 | | |
| CORTRAK 2 Enteral Access System for placing nasoenteral feeding tubes | MIB48 | | |
| Mental wellbeing and independence for older people | QS137 | | |
| Transition between inpatient hospital settings and community or care home settings for adults with social care needs | QS136 | | |
| Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis | CG95 | | |
| Coexisting severe mental illness and substance misuse: community health and social care services | NG58 | | |
| Spasticity in under 19s: management | CG145 | | |
| OCS Heart system for heart transplant | MIB86 | | |
| CytoSorb therapy for sepsis | MIB87 | | |
| Sternal Talon for sternal closure in cardiothoracic surgery | MIB88 | | |
| Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions | MIB89 | | |
| Nivolumab for previously treated advanced renal cell carcinoma | TA417 | | |
| Dapagliflozin in triple therapy for treating type 2 diabetes | TA418 | | |
| Apremilast for treating moderate to severe plaque psoriasis | TA419 | | |
| Dapagliflozin in combination therapy for treating type 2 diabetes | TA288 | | |
| Endoscopic transluminal pancreatic necrosectomy | HTG421 | | |
| Percutaneous insertion of craniocaudal expandable implants for vertebral compression fracture | HTG422 | | |
| Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy for treating morbid obesity | HTG423 | | |
| High-throughput non-invasive prenatal testing for fetal RHD genotype | HTG420 | | |
| Minimal change disease and focal segmental glomerulosclerosis in adults: rituximab | ES1 | | |
| Physical health of people in prison | NG57 | | |
| Psychosis and schizophrenia in children and young people: recognition and management | CG155 | | |
| Needle-free arterial non-injectable connector | MIB85 | | |
| Elbasvir–grazoprevir for treating chronic hepatitis C | TA413 | | |
| Cobimetinib in combination with vemurafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma | TA414 | | |
| Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitor | TA415 | | |
| Coeliac disease | QS134 | | |
| Children's attachment | QS133 | | |
| Single-incision short sling mesh insertion for stress urinary incontinence in women | HTG419 | | |
| Woundchek Protease Status for assessing elevated protease status in chronic wounds | MIB83 | | |
| Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion | TA409 | | |
| Talimogene laherparepvec for treating unresectable metastatic melanoma | TA410 | | |
| Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancer | TA411 | | |
| Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases | TA412 | | |
| Crizotinib for untreated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer | TA406 | | |
| Pegaspargase for treating acute lymphoblastic leukaemia | TA408 | | |
| Secukinumab for treating active ankylosing spondylitis | TA407 | | |
| Miniature lens system implantation for advanced age-related macular degeneration | HTG418 | | |
| Multimorbidity: clinical assessment and management | NG56 | | |
| Intravenous fluid therapy in children and young people in hospital | QS131 | | |
| Social care for older people with multiple long-term conditions | QS132 | | |
| Harmful sexual behaviour among children and young people | NG55 | | |
| QuikRead go for C-reactive protein testing in primary care | MIB78 | | |
| FLEXISEQ for osteoarthritis | MIB80 | | |
| Alere Afinion CRP for C-reactive protein testing in primary care | MIB81 | | |
| Mental health problems in people with learning disabilities: prevention, assessment and management | NG54 | | |
| Contraception | QS129 | | |
| Transition between inpatient mental health settings and community or care home settings | NG53 | | |
| Stable angina: management | CG126 | | |
| Acute upper gastrointestinal bleeding in over 16s: management | CG141 | | |
| Axxent electronic brachytherapy system for early stage breast cancer | MIB76 | | |
| OSNA for colon cancer staging | MIB77 | | |
| Bosutinib for previously treated chronic myeloid leukaemia | TA401 | | |
| Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatin | TA402 | | |
| Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxel | TA391 | | |
| Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer | TA403 | | |
| Degarelix for treating advanced hormone-dependent prostate cancer | TA404 | | |
| Trifluridine–tipiracil for previously treated metastatic colorectal cancer | TA405 | | |
| Early years: promoting health and wellbeing in under 5s | QS128 | | |
| Palliative care for adults: strong opioids for pain relief | CG140 | | |
| Motor neurone disease | QS126 | | |
| Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blasts | TA399 | | |
| Nivolumab in combination with ipilimumab for treating advanced melanoma | TA400 | | |
| Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated | TA387 | | |
| Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen | TA259 | | |
| Percutaneous endoscopic laser balloon pulmonary vein isolation for atrial fibrillation | HTG417 | | |
| QTUG for assessing falls risk and frailty | MIB73 | | |
| Stretta System for gastro-oesophageal reflux disease | MIB74 | | |
| Non-Hodgkin's lymphoma: diagnosis and management | NG52 | | |
| Alair bronchial thermoplasty system for adults with severe difficult to control asthma | MIB71 | | |
| Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures | CG64 | | |
| Non-alcoholic fatty liver disease (NAFLD): assessment and management | NG49 | | |
| Oral health for adults in care homes | NG48 | | |
| Cellvizio confocal endomicroscopy system for characterising pancreatic cysts | MIB69 | | |
| Mobi-C for cervical disc replacement | MIB70 | | |
| Home care for older people | QS123 | | |
| Bronchiolitis in children | QS122 | | |
| Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia | TA393 | | |
| Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia | TA394 | | |
| Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer | TA395 | | |
| Trametinib in combination with dabrafenib for treating unresectable or metastatic melanoma | TA396 | | |
| Adalimumab for treating moderate to severe hidradenitis suppurativa | TA392 | | |
| Transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stenting | HTG415 | | |
| Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodules | HTG416 | | |
| Breast cancer | QS12 | | |
| S-Cath System for suprapubic catheterisation | MIB68 | | |
| Complicated urinary tract infections: ceftolozane/tazobactam | ESNM74 | | |
| Complicated intra-abdominal infections: ceftolozane/tazobactam | ESNM75 | | |
| Haematological cancers: improving outcomes | NG47 | | |
| Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes | TA390 | | |
| Endovenous mechanochemical ablation for varicose veins | HTG414 | | |
| Reversal of the anticoagulant effect of dabigatran: idarucizumab | ESNM73 | | |
| CareLink network service for remote monitoring of people with cardiac devices | MIB64 | | |
| Prolaris gene expression assay for assessing long-term risk of prostate cancer progression | MIB65 | | |
| Secca System for faecal incontinence | MIB66 | | |
| LATITUDE NXT Patient Management System for monitoring cardiac devices at home | MIB67 | | |
| ImmunoCAP ISAC 112 for multiplex allergen testing | HTG413 | | |
| Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction | TA388 | | |
| Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer | TA389 | | |
| Microwave ablation for treating liver metastases | HTG409 | | |
| Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension | HTG410 | | |
| Percutaneous interlaminar endoscopic lumbar discectomy for sciatica | HTG411 | | |
| Percutaneous transforaminal endoscopic lumbar discectomy for sciatica | HTG412 | | |
| Antimicrobial stewardship | QS121 | | |
| Controlled drugs: safe use and management | NG46 | | |
| Stroke in adults | QS2 | | |
| Routine preoperative tests for elective surgery | NG45 | | |